Tower Research Capital (TRC)’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,220
Closed -$10.8K 6135
2024
Q3
$10.8K Sell
2,220
-643
-22% -$3.37K ﹤0.01% 3716
2024
Q2
$14.6K Buy
2,863
+267
+10% +$1.32K ﹤0.01% 3941
2024
Q1
$14.8K Sell
2,596
-1,286
-33% -$7.99K ﹤0.01% 3279
2023
Q4
$24.9K Sell
3,882
-1,926
-33% -$10.9K ﹤0.01% 3522
2023
Q3
$26.3K Buy
5,808
+2,923
+101% +$18.9K ﹤0.01% 3131
2023
Q2
$17.1K Sell
2,885
-7,107
-71% -$43.6K ﹤0.01% 3526
2023
Q1
$53K Buy
9,992
+5,233
+110% +$35.5K ﹤0.01% 2446
2022
Q4
$25K Buy
4,759
+1,908
+67% +$12.1K ﹤0.01% 2939
2022
Q3
$23K Buy
2,851
+906
+47% +$9.14K ﹤0.01% 3835
2022
Q2
$21K Sell
1,945
-14,531
-88% -$173K ﹤0.01% 3769
2022
Q1
$237K Buy
+16,476
New +$281K ﹤0.01% 1609

Other funds holding EXAI

Tower Research Capital (TRC)'s EXAI Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 2,220 shares — an estimated $10.8K sold.

Tower Research Capital (TRC) first reported a position in EXAI in Q1 2022 and held it in 11 quarters. The position peaked at $237K in Q1 2022. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,220 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $10.8K.
  • Tower Research Capital (TRC) first reported a position in Exscientia Plc American Depositary Shares in Q1 2022 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Exscientia Plc American Depositary Shares position peaked at $237K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.